General
Preferred name
OXYMETHOLONE
Synonyms
Protanabol ()
Oximetolona ()
Nastenon ()
HMD ()
Anapolon 50 ()
Oxymetholone ciii ()
Anadrol-50 ()
Anapolon ()
Anasteron ()
NSC-26,198 ()
NSC-26198 ()
Anadrol ()
Oximetholone ()
CI-406 ()
Pardroyd ()
Oxymetholone ()
P&D ID
PD009300
CAS
434-07-1
Tags
natural product
drug
available
Approved by
FDA
First approval
1972
Drug Status
illicit
approved
Drug indication
Androgen
Aplastic anemia
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
TOXICITY
May cause cancer.; The uncontrolled misuse of oxymetholone can lead to a large variety of detrimental effects, the most often reported of which are cardiovascular events.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
9
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
21
Molecular Weight
332.24
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
0
cLogP
4.4
TPSA
57.53
Fraction CSP3
0.86
Chiral centers
7.0
Largest ring
6.0
QED
0.51
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
